View Older Stories View More Recent Stories
-
fuboTV to Present at Upcoming Virtual Investor Conferences
-
Roth Capital Reiterates Buy Rating on Sunnova (NOVA) After Securing Capacity
-
Revolve Group (RVLV) PT Raised to $41 at Roth Capital
-
Fathom Holdings Inc. (FTHM) PT Raised to $55 at Roth Capital, 'January EHS Reaccelerate to Remain Near Highs'
-
DMC Global (BOOM) PT Raised to $55 at Roth Capital, Following Earnings
-
Planet Fitness (PLNT) PT Raised to $75 at Roth Capital
-
Roth Capital Starts Montauk Renewables, Inc. (MNTK) at Buy
-
UPDATE: Roth Capital Upgrades Coeur d'Alene Mines (CDE) to Buy
-
Cambium Networks Reports Fourth Quarter and Full Year 2020 Financial Results
-
Bio-Path Holdings, Inc. Announces Closing of $13.0 Million Public Offering of Common Stock
-
Cambium Networks Reports Fourth Quarter and Full Year 2020 Financial Results
-
Tilray (TLRY) PT Raised to $25 at Roth Capital
-
Phunware Closes Public Offering of Common Stock
-
QuickLogic (QUIK) PT Raised to $7 at Roth Capital
-
Magnachip Semiconductor (MX) PT Raised to $30 at Roth Capital
-
SiTime Corp. (SITM) Prices 3M Share Follow-On Offering at $127/Sh
-
SunPower (SPWR) PT Raised to $40 at Roth Capital
-
SiTime Corporation Announces Pricing of Follow-on Public Offering
-
SiTime Corporation Announces Pricing of Follow-on Public Offering
-
Kalvista Pharmaceuticals Inc (KALV) PT Raised to $55 at Roth Capital
-
Hexo Corp. (HEXO:CN) (HEXO) PT Raised to Cdn$4.50 at Roth Capital, After Acquiring Competitor
-
Pre-Open Stock Movers 02/17: (TUSK) (VSTM) (CSOD) Higher; (SHIP) (AFI) (KAR) Lower (more...)
-
Roth Capital Downgrades Kodiak Sciences Inc. (KOD) to Neutral
-
SolarEdge Technologies (SEDG) PT Raised to $380 at Roth Capital Ahead of Non-Solar Margin Improvement
-
Roth Capital Starts DiaMedica Therapeutics Inc. (DMAC) at Buy
-
United States Antimony Corporation Announces Closing of $14.3 Million Registered Direct Offering
-
KalVista Pharmaceuticals Announces the Closing of its Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
GT Biopharma Announces Closing of $23.7 Million Public Offering
-
GoldMining Announces Launch of Gold Royalty IPO and Application to List on the NYSE American
-
Bio-Path (BPTH) Announces Pricing of $13 Million Public Offering of Common Stock at $7.60/sh
-
Bio-Path Holdings, Inc. Announces Pricing of $13.0 Million Public Offering of Common Stock
-
New Age Beverages (NBEV) Announces $58 Million Private Placement of Common Stock
-
NewAge Announces $58 Million Private Placement
-
UPDATE: Roth Capital Starts CuriosityStream Inc. (CURI) at Buy
-
Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock
-
Limbach Holdings Closes Public Offering of Common Stock
-
Assertio Holdings, Inc. Announces Closing of Registered Direct Offering of $34.3 Million
-
InvestorNewsBreaks – KemPharm Inc. (NASDAQ: KMPH) Secures $52.4M in Follow-on and $44M in Warrant Exchange Transaction
-
InvestorNewsBreaks – GT Biopharma Inc. (GTBP) Announces Public Offering Pricing, Uplists to Nasdaq Capital Market
-
Roth Capital Starts Applied DNA Sciences (APDN) at Buy
-
Phunware (PHUN) Prices 11.1M Share Common Stock Offering at $2.25/each
-
Phunware, Inc. Announces Pricing of Public Offering of Common Stock
-
Phunware (PHUN) Announces Proposed Common Share Offering
-
Phunware, Inc. Announces Proposed Public Offering of Common Stock
-
Dynatronics (DYNT) PT Raised to $2.10 at Roth Capital, Following Earnings
-
Orion Energy Systems (OESX) PT Lowered to $14 at Roth Capital, Following Earnings
-
LiveXLive Media (LIVX) PT Raised to $9 at Roth Capital; Takeover Could Be Near
-
GT Biopharma Announces Pricing of $23,650,000 Public Offering and Uplisting to The Nasdaq Capital Market
-
Roth Capital Starts PLBY Group, Inc. (PLBY) at Buy
-
KalVista Pharmaceuticals (KALV) Prices 5.375M Share Upsized Common Offering at $36/Sh
